Deep Dive • Issue 02 • Sirtuins & NAD+
LONGEVITY LATEST • DEEP DIVE
Sirtuins and NAD+ Metabolism:
The Repair Enzymes at the Heart of Longevity Science
Issue 02 Companion Article • March 2026 • ~1,300 words • 6 min read
Why Sirtuins Matter
If you follow longevity science, you have encountered sirtuins. They appear in almost every discussion of caloric restriction, NAD+ supplementation, and biological ageing. They have been called “longevity genes,” a label that is both partially accurate and dangerously oversimplified. Sirtuins are not genes — they are enzymes encoded by genes. And their relationship to human lifespan is considerably more nuanced than most popular coverage suggests.
In this Deep Dive, we explain what sirtuins actually do, why their dependence on NAD+ matters for the supplements we graded in Issue 02, and where the evidence stands on targeting them for healthy ageing. If you read only one thing about NAD+ biology this year, make it this.
The Sirtuin Family: Seven Enzymes, Different Jobs
Mammals have seven sirtuins (SIRT1 through SIRT7), each located in different parts of the cell and performing distinct functions. What unites them is their dependence on NAD+ as a co-substrate. Without adequate NAD+, sirtuins cannot function. This is the core reason NAD+ decline with age has generated so much research interest.
SIRT1, the most studied member, operates primarily in the cell nucleus and cytoplasm. It deacetylates proteins involved in DNA repair, inflammation control, and metabolic regulation — including PGC-1α, a master regulator of mitochondrial biogenesis. When SIRT1 is active, cells produce more mitochondria, burn fat more efficiently, and mount better stress responses. In animal models, SIRT1 overexpression is associated with improved metabolic health and modest lifespan extension.
SIRT3, the primary mitochondrial sirtuin, governs the enzymes of the electron transport chain and the citric acid cycle. It is essential for efficient energy production and for controlling reactive oxygen species (ROS) — the metabolic byproducts that, when unchecked, damage DNA, proteins, and lipid membranes. SIRT3 knockout mice develop accelerated ageing phenotypes, while caloric restriction — the most reliable lifespan-extending intervention in animals — robustly increases SIRT3 activity.
The remaining sirtuins have more specialised roles. SIRT2 regulates cell division and fat metabolism. SIRT4 and SIRT5 operate in the mitochondria with roles in amino acid and fatty acid metabolism. SIRT6 maintains telomere integrity and genomic stability. SIRT7 supports ribosomal DNA transcription. Each has distinct Km values for NAD+ — meaning they require different NAD+ concentrations to function optimally. This is a critical detail that the “more NAD+ is always better” narrative ignores entirely.
The NAD+ Connection: Not All Precursors Are Equal
In Issue 02, we graded three NAD+ precursors: NMN, NR, and niacin. All three raise circulating NAD+ levels, but their relationship to sirtuin activation is not straightforward.
Nicotinamide (niacinamide) — a common form of vitamin B3 and a metabolic byproduct of sirtuin reactions themselves — is a known sirtuin inhibitor at high concentrations. When sirtuins use NAD+ to deacetylate their targets, they produce nicotinamide as a waste product. This nicotinamide then feeds back to inhibit further sirtuin activity, creating a natural brake on the system. Supplementing with high-dose nicotinamide could, in theory, amplify this inhibitory feedback. This is why longevity researchers have gravitated toward NR and NMN as “cleaner” NAD+ precursors — they enter NAD+ biosynthesis without generating the same inhibitory feedback loop.
Niacin (nicotinic acid) takes a different route entirely. It enters NAD+ synthesis through the Preiss-Handler pathway, which does not produce nicotinamide as an intermediate. The 2020 Cell Metabolism study showing 8-fold NAD+ increases in patients and healthy controls used niacin, not NR or NMN. The January 2026 Christen et al. trial in Nature Metabolism provided the first direct human comparison: NR and NMN both doubled circulating NAD+ over 14 days through a gut-bacteria-mediated conversion to nicotinic acid, while nicotinamide raised NAD+ only acutely. This suggests that NR and NMN may ultimately work through the same pathway as niacin itself — a finding that undermines much of the marketing narrative around “direct” NAD+ precursors.
What Actually Activates Sirtuins in Humans?
The most reliable sirtuin activator is not a supplement — it is caloric restriction. Decades of animal research and emerging human data confirm that reducing caloric intake increases NAD+ levels, activates SIRT1 and SIRT3, and improves metabolic health markers. Exercise — particularly endurance exercise — also robustly activates SIRT1 and SIRT3 through AMPK-mediated NAD+ increases.
The TAME trial (Targeting Aging with Metformin) is currently investigating whether metformin, which activates AMPK and raises NAD+ indirectly, can delay age-related diseases in non-diabetic adults. Berberine, which we spotlighted in Issue 02, activates AMPK through multiple routes and may preserve NAD+ levels better than metformin by avoiding direct mitochondrial Complex I inhibition — though this theoretical advantage has not been confirmed in human longevity trials.
Resveratrol, famously promoted by David Sinclair as a direct sirtuin activator, has a complicated legacy. While it showed SIRT1 activation in early studies, subsequent work revealed that the activation was indirect and that resveratrol’s bioavailability in humans is extremely low. A 2014 meta-analysis found no significant mortality benefit from resveratrol supplementation in animal models when studies with methodological concerns were excluded. We grade resveratrol as a standalone longevity supplement at Evidence Grade D.
The Frontier: Where Sirtuin Research Is Heading
The field is moving beyond crude NAD+ supplementation toward more targeted approaches. Several research groups are developing small-molecule sirtuin activators (STACs) that can bind specific sirtuins directly, bypassing the need to raise systemic NAD+ levels. SRT2104, a SIRT1-specific activator, has completed Phase II trials for psoriasis and metabolic dysfunction, though results were modest.
Tissue-specific NAD+ delivery is another active area. The recognition that gut bacteria convert NR and NMN to nicotinic acid before absorption (Christen et al., 2026) has prompted interest in formulations that bypass gut metabolism — including liposomal NMN and intravenous NR. A pilot clinical study of IV NR was published in 2024, with safety data that supports further investigation.
Epigenetic research is also intersecting with sirtuin biology. SIRT1 and SIRT6 directly modify histone acetylation patterns — the same epigenetic marks measured by biological age clocks. Whether sirtuin activation can meaningfully reverse epigenetic ageing in humans remains an open and important question.
What This Means for You
The evidence supports a hierarchy of interventions for sirtuin support, in order of confidence:
1. Caloric moderation and regular exercise are the most evidence-backed ways to activate sirtuins. These are free, well-tolerated, and supported by decades of data. Do these first.
2. If you want to supplement for NAD+ support, niacin offers the longest clinical track record and the best cost-effectiveness. Start at 100 mg/day and increase gradually to manage flushing. NR is a reasonable alternative if you cannot tolerate niacin.
3. NMN lacks the clinical outcome data to justify its premium price. If you are already taking it, the evidence does not suggest harm — but it does not yet suggest meaningful benefit for healthy adults either.
4. Avoid high-dose nicotinamide (niacinamide) if your goal is sirtuin activation. The inhibitory feedback loop is well-characterised and theoretically counterproductive.
5. Do not rely on resveratrol as a primary sirtuin strategy. Bioavailability is too low to achieve meaningful activation at oral supplementation doses.
Sources and Further Reading
1. Imai S, Guarente L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 2014;24(8):464-471. PMID: 24786309
2. Covarrubias AJ, et al. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22:119-141. PMID: 33353981
3. Christen S, Cuenoud B, et al. Comparative analysis of NAD+ precursors in humans. Nature Metabolism. 2025 [published Jan 2026].
4. Rajman L, et al. Therapeutic potential of NAD-boosting molecules. Cell Metab. 2018;27(3):529-547. PMID: 29514064
5. Suomalainen A, et al. Niacin cures systemic NAD+ deficiency and improves muscle performance. Cell Metab. 2020;31(6):1078-1090. PMID: 32386566
6. Martens CR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9:1286. PMID: 29599443
7. McDonnell ME, et al. Nicotinamide riboside for peripheral artery disease: the NICE trial. Nat Commun. 2024;15:6839.
8. Howitz KT, et al. Small molecule activators of sirtuins. Nature. 2003;425:191-196. PMID: 12939617
9. Mitchell SJ, et al. Nicotinamide improves aspects of healthspan, but not lifespan, in mice. Cell Metab. 2018;27(3):667-676. PMID: 29514072
10. Fahy GM, et al. Reversal of epigenetic aging and immunosenescent trends in humans. Aging Cell. 2019;18(6):e13028. PMID: 31496122
11. Johnson AA, et al. Human age reversal: fact or fiction? Aging Cell. 2022;21(8):e13664. PMID: 35778957
12. Zhang et al. Efficacy of oral NMN on glucose and lipid metabolism: systematic review. Crit Rev Food Sci Nutr. 2025;65(22):4382-4400. PMID: 39116016
© 2026 Longevity Latest • longevitylatest.com